• Raluca Tulin "Carol Davila" University of Medicine, Bucharest, Romania
  • Constantin Oprescu General Surgery Department, Emergency Clinical Hospital, Bucharest, Romania
  • Anca Macovei Oprescu Gastroenterology Department, "Prof. Dr. Agrippa Ionescu", Hospital, Bucharest, Romania
  • Dana Paula Venter General Surgery Department of Pediatrics, “Grigore Alexandrescu”, Hospital, Bucharest, Romania
  • Cornelia Nitipir Oncology Department, Elias University Hospital, Bucharest, Romania
  • Dan Nicolae Păduraru General Surgery Department, University Emergency Hospital, Bucharest, Romania & “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
  • Iulian Slavu General Surgery Department, Emergency Clinical Hospital, Bucharest, Romania
  • Adrian Tulin General Surgery Department, "Prof. Dr. Agrippa Ionescu" Hospital, Bucharest, Romania
Keywords: COVID-19, sars-cov2, Thyroidv, De Quervain, thyroiditis


The Sars Cov-2 virus produced an impact on the health system never seen before in modern times. Due to the large number of patients infected, clinical practitioners but also pathologists started to observe that other organs besides the lungs were damaged by the virus. The mechanisms through which this happens are not entirely clear mainly due to the fact that this is a novel disease and we are still learning new information on a daily basis. This multi-visceral approach of the virus to the human body wrecks havoc and is hard to contain. Our study and case presentation focused on the impact the Sars Cov-2 virus has on the thyroid gland, clinical signs, and treatment options.


[1] RM Ruggeri, A Campennì, M Siracusa, G Frazzetto, D Gullo. Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic. Hormones (Athens). 2020;16:1-3.
[2] S Ippolito, F Dentali, ML Tanda. SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report. J Endocrinol Invest. 2020; 12:1-2.
[3] R Ruano, et al. Subacute thyroiditis might be a complication triggered by SARS-CoV-2. Endocrinol Diabetes Nutr. 2021; 68(10): 755–756.
[4] A Brancatella, D Ricci, N Viola, D Sgrò, F Santini, F Latrofa. Subacute thyroiditis after SARS-COV-2 infection. J Clin Endocrinol Metab. 2020; 105(7):276.
[5] R Desailloud, D Hober. Viruses and thyroiditis: an update. Virol J. 2009; 6:5
[6] A Tabassom, MA Edens. De Quervain Thyroiditis. [Updated 2020 Jul 15]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan. Available from:
[7] D Dworakowska, AB Grossman. Thyroid disease in the time of COVID-19. Endocrine. 2020; 68:471-474.
[8] Le Chang, Ying Yan, Lunan Wang, Coronavirus Disease 2019: Coronaviruses and Blood Safety, Transfusion Medicine Reviews, 2020, 34:75-80.
[9] A Saha, P Batra, KY Vilhekar, P Chaturvedi. Post-varicella myasthenia gravis. Singapore Med J. 2007; 48(6):177-80.
[10] A Vojdani, D Kharrazianv. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol. 2020; 217: 108480.
[11] L Wei, S Sun, C Xu, J Zhang, Y Xu, H Zhu et al Pathology of the thyroid in severe acute respiratory syndrome. Hum Pathol, 2007; 38:95–102.
[12] A Bindra, GD Braunstein. Thyroiditis. Am Fam Physician. 2006;73(10):1769-76.
How to Cite
Tulin, R., Oprescu, C., Oprescu, A. M., Venter, D. P., Nitipir, C., Păduraru, D., Slavu, I., & Tulin, A. (2022). SUBACUTE THYROIDITIS CAN BE CONSIDERED A COMPLICATION OF SARS-COV2 INFECTION-CASE PRESENTATION. Romanian Journal of Clinical Research, 5(2). Retrieved from